Stockreport

Spero's stock slides after antibiotic flops in Phase II trial [Yahoo! Finance]

Shattuck Labs, Inc.  (STTK) 
PDF The company was quick to note that whilst SPR720 showed antimicrobial activity, “the interim analysis did not show sufficient separation from placebo.” Spero also noted [Read more]